Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 4 | 6 |
| List of Tables | 7 | 1 |
| List of Figures | 8 | 2 |
| Introduction | 10 | 1 |
| GBI Research Guidance | 10 | 1 |
| Drug Delivery Devices - Market Characterization | 11 | 12 |
| Global Drug Delivery Device Market, Revenue ($m), 2003-2010 | 11 | 1 |
| Global Drug Delivery Device Market, Revenue Forecast ($m), 2010-2017 | 12 | 1 |
| Global Drug Delivery Device Market, Key Technology Trends | 13 | 1 |
| Future Applications of Nano-Enabled Drug Delivery | 13 | 2 |
| Increased Application of Microneedle Enhanced Drug Delivery to Include Skin Cancer | 15 | 1 |
| Smart Infusion Pumps Equipped with Computerized Prescriber Order Entry (CPOE), and Bar-Coded Medication Administration (BCMA) Prevent Medication Errors | 15 | 1 |
| Specialized Drug Delivery Systems to Deliver Biologics and Biotech Compounds will Augment Market Growth | 15 | 1 |
| Transcutaneous Immunization (TCI) - Needle-Free Drug Delivery Technology used as Immunostimulant | 16 | 1 |
| Global Drug Delivery Device Market, Market Dynamics | 17 | 1 |
| Market Drivers | 17 | 1 |
| Drug Delivery Devices to be used for a Number of Indications such as Asthma, COPD, Diabetes and Hormonal Treatments | 17 | 1 |
| Extension of Patent Life and Differentiation of Products with Advanced Drug Delivery Technology to Drive Market | 18 | 1 |
| Shift in Demand from a Hospital to Home Healthcare Equipment will Increase the Overall Revenues of Drug Delivery Device Market | 19 | 1 |
| Market Restraints | 20 | 1 |
| Regulatory Hurdles and Challenges for Development of Innovative Drug Delivery Devices to Limit Market Growth | 20 | 1 |
| High Cost of Advanced Drug Delivery Devices in Emerging Countries to Deter Market Growth | 21 | 1 |
| Ineffective Pulmonary Drug Delivery Systems and Dosing Inconsistency to Impede Widespread Market Acceptance for Devices | 21 | 1 |
| Global Drug Delivery Device Market, Key Company Share (%), 2010 | 22 | 1 |
| Global Drug Delivery Device Market - Category Analysis and Forecasts | 23 | 28 |
| Drug Delivery Devices | 23 | 1 |
| Central Venous Catheters | 23 | 1 |
| Central Venous Catheter Market, Global, Revenue ($m), 2003-2010 | 24 | 1 |
| Central Venous Catheter Market, Global, Revenue Forecast ($m), 2010-2017 | 25 | 1 |
| Central Venous Catheters - Market Dynamics | 26 | 1 |
| Market Drivers | 26 | 1 |
| Increase in the Incidence Rate of Diseases that Require Nutritional Support to Augment the Market Growth of Central Venous Catheters | 26 | 1 |
| The Home Parenteral Nutrition (HPN) Sector will Witness Strong Market Growth Leading to an Increase in Demand for Central Venous Catheters | 26 | 1 |
| Increased Awareness and Lack of Reimbursements for Hospital Acquired Infections will have a Positive Impact on the Antimicrobial Central Venous Catheter Market Growth | 27 | 1 |
| Market Restraints | 27 | 1 |
| Complications Associated with Central Venous Catheter Usage to Limit its Adoption Rate | 27 | 1 |
| Increasing Preference for Enteral Nutrition (EN) will Restrain Market Growth | 28 | 1 |
| Central Venous Catheter Market, Global, Company Share (%), 2010 | 29 | 1 |
| Infusion Systems | 30 | 1 |
| Infusion System Market, Global, Revenue ($m), 2003-2010 | 30 | 1 |
| Infusion System Market, Global, Revenue Forecast ($m), 2010-2017 | 31 | 1 |
| Infusion Systems - Market Dynamics | 32 | 1 |
| Market Drivers | 32 | 1 |
| Increased Level of Control, Accuracy and Precision in Infusion Systems Leading To a Reduction in Medication Errors, thereby Increasing Growth of the Infusion Pump Market | 32 | 1 |
| Home Healthcare and Integration of Healthcare IT Systems with Infusion Systems to Boost Infusion System Market Growth | 33 | 1 |
| Improvement Initiative Taken by Food Drug Authority (FDA) to Reduce Adverse Events Related To Infusion Pumps Used to Propel the Growth of the Market | 33 | 1 |
| Elderly Population and Rise of Neurological Conditions and Chronic Diseases such as Cancer and Diabetes to Drive Growth | 34 | 1 |
| Market Restraints | 34 | 1 |
| High Number of Malfunction Cases, Medication Errors and Adverse Events Leading to Product Recalls will Deter Market Growth for Infusion Systems | 34 | 1 |
| Demand for Refurbished Infusion Pumps to Limit Adoption of New Systems | 35 | 2 |
| Infusion System Market, Global, Company Share (%), 2010 | 37 | 1 |
| Metered Dose Inhaler Devices | 38 | 1 |
| Metered Dose Inhaler Device Market, Global, Revenue ($m), 2003-2010 | 38 | 1 |
| Metered Dose Inhaler Device Market, Global, Revenue Forecasts ($m), 2010-2017 | 39 | 1 |
| Metered Dose Inhaler Devices - Market Dynamics | 40 | 1 |
| Market Drivers | 40 | 1 |
| Huge Population Afflicted with Respiratory Disorders such as Asthma and Chronic Obstructive Pulmonary Disease to Drive Metered Dose Inhaler Market | 40 | 1 |
| Metered Dose Inhalers to Drive Market Growth Owing to Better Efficiency and Tolerance among Children Suffering from Asthma | 41 | 1 |
| Better Efficacy of Pressurized Metered Dose Inhalers (pMDIs) for Administering Bronchodilator Aerosols to Mechanically Ventilated Patients to Accelerate Market Growth | 41 | 1 |
| Product Differentiation by Means of Improved Inhaler Devices to Boost Market Growth | 41 | 1 |
| Market Restraints | 42 | 1 |
| Poor Patient Compliance and Drawbacks of Metered Dose Inhaler Devices Reducing Physician and Patient Adoption Rate | 42 | 1 |
| Under Diagnosis of COPD to Affect the Market Volume of Metered Dose Inhaler Devices | 42 | 1 |
| Metered Dose Inhaler Device Market, Global, Company Share (%), 2010 | 43 | 1 |
| Needle-Free Injections | 44 | 1 |
| Needle-Free Injection Market, Global, Revenue ($m), 2003-2010 | 44 | 2 |
| Needle-Free Injection Market, Global, Revenue Forecasts ($m), 2010-2017 | 46 | 1 |
| Needle-Free Injections - Market Dynamics | 47 | 1 |
| Market Drivers | 47 | 1 |
| Improving Patient Acceptance and Compliance for Needle-Free Injections to Drive Market Growth | 47 | 1 |
| Needle-Free Delivery an Important Aspect for New Treatment Development and a Strategy for Companies to Achieve Commercial Success | 47 | 1 |
| New Collaborations in Support for Advanced Clinical Research into Needle Free Injections to Boost Market Growth | 48 | 1 |
| Biologics and Biotechnology Based Compounds which need to be Delivered Using Specialized Delivery Systems have also Fuelled Demand for Needle-Free Injections | 48 | 1 |
| Market Restraints | 49 | 1 |
| Constraints of Needle-Free Injection Technology and its Drawback to Limit its Market Growth | 49 | 1 |
| Lack of Awareness of Applications and High Cost of Needle-Free Injections in Emerging Countries is Pulling Down Overall Market Growth | 49 | 1 |
| Needle-Free Injection Market, Global, Company Share (%), 2010 | 50 | 1 |
| Global Drug Delivery Device Market - Country Analysis and Forecasts | 51 | 25 |
| Drug Delivery Device Market - Cross-Country Analysis | 51 | 1 |
| Revenue Forecasts, By Country, 2003-2017 | 52 | 1 |
| Drug Delivery Device Market, the US, Revenue ($m), 2003-2010 | 52 | 1 |
| Drug Delivery Device Market, the US, Revenue ($m), 2010-2017 | 53 | 1 |
| Drug Delivery Device Market, Canada, Revenue ($m), 2003-2010 | 54 | 1 |
| Drug Delivery Device Market, Canada, Revenue ($m), 2010-2017 | 55 | 1 |
| Drug Delivery Device Market, UK, Revenue ($m), 2003-2010 | 56 | 1 |
| Drug Delivery Device Market, the UK, Revenue ($m), 2010-2017 | 57 | 1 |
| Drug Delivery Device Market, Germany, Revenue ($m), 2003-2010 | 58 | 1 |
| Drug Delivery Device Market, Germany, Revenue ($m), 2010-2017 | 59 | 1 |
| Drug Delivery Device Market, France, Revenue ($m), 2003-2010 | 60 | 1 |
| Drug Delivery Device Market, France, Revenue ($m), 2010-2017 | 61 | 1 |
| Drug Delivery Device Market, Italy, Revenue ($m), 2003-2010 | 62 | 1 |
| Drug Delivery Device Market, Italy, Revenue ($m), 2010-2017 | 63 | 1 |
| Drug Delivery Device Market, Spain, Revenue ($m), 2003-2010 | 64 | 1 |
| Drug Delivery Device Market, Spain, Revenue ($m), 2010-2017 | 65 | 1 |
| Drug Delivery Device Market, Japan, Revenue ($m), 2003-2010 | 66 | 1 |
| Drug Delivery Device Market, Japan, Revenue ($m), 2010-2017 | 67 | 1 |
| Drug Delivery Device Market, China, Revenue ($m), 2003-2010 | 68 | 1 |
| Drug Delivery Device Market, China, Revenue ($m), 2010-2017 | 69 | 1 |
| Drug Delivery Device Market, India, Revenue ($m), 2003-2010 | 70 | 1 |
| Drug Delivery Device Market, India, Revenue ($m), 2010-2017 | 71 | 1 |
| Drug Delivery Device Market, Australia, Revenue ($m), 2003-2010 | 72 | 1 |
| Drug Delivery Device Market, Australia, Revenue ($m), 2010-2017 | 73 | 1 |
| Drug Delivery Device Market, Brazil, Revenue ($m), 2003-2010 | 74 | 1 |
| Drug Delivery Device Market, Brazil, Revenue ($m), 2010-2017 | 75 | 1 |
| Global Drug Delivery Device Market - Competitive Assessment | 76 | 15 |
| Drug Delivery Devices, Market Opportunities and Risk Evaluation | 76 | 2 |
| GlaxoSmithKline plc | 78 | 1 |
| Business Overview | 78 | 1 |
| Key Products | 78 | 1 |
| Boehringer Ingelheim GmbH | 79 | 1 |
| Business Overview | 79 | 1 |
| Key Products | 80 | 1 |
| AstraZeneca plc | 81 | 1 |
| Business Overview | 81 | 1 |
| Key Products | 82 | 1 |
| Hospira, Inc. | 83 | 1 |
| Business Overview | 83 | 1 |
| Key Products | 84 | 1 |
| CareFusion Corporation | 85 | 1 |
| Business Overview | 85 | 1 |
| Key Products | 86 | 1 |
| Baxter International Inc. | 87 | 1 |
| Business Overview | 87 | 1 |
| Key Products | 88 | 1 |
| Teleflex Incorporated | 88 | 1 |
| Business Overview | 88 | 1 |
| Key Products | 89 | 1 |
| INJEX - Equidyne Systems | 90 | 1 |
| Business Overview | 90 | 1 |
| Key Products | 90 | 1 |
| Drug Delivery Device Market - Pipeline Product Analysis | 91 | 18 |
| Drug Delivery Devices - Pipeline Product Summary | 91 | 1 |
| Injectable Drug Delivery | 92 | 1 |
| Injectable Drug Delivery - List of Pipeline Products | 92 | 2 |
| Injectable Drug Delivery - Profiles of Key Pipeline Products | 94 | 1 |
| Ambulin | 94 | 1 |
| Bronchio-Adventitial Drug Delivery Catheter | 94 | 1 |
| NovoTwist Needle | 94 | 1 |
| VIBEX MTX | 94 | 1 |
| EpiCard | 94 | 1 |
| Metered Dose Inhalers | 95 | 1 |
| Metered Dose Inhalers - List of Pipeline Products | 95 | 1 |
| Metered Dose Inhalers - Profiles of Key Pipeline Products | 95 | 1 |
| BK361 Easifill | 95 | 1 |
| VAL020 MDI Valve | 95 | 1 |
| Infusion Systems | 96 | 1 |
| Infusion Systems - List of Pipeline Products | 96 | 1 |
| Infusion Systems - Profiles of Key Pipeline Products | 97 | 1 |
| ALN-HTT Infusion System (Medtronic, Inc.) | 97 | 1 |
| Delos PUMP (Delpor, Inc.) | 97 | 1 |
| Medallion System (Advanced Bionics, LLC) | 97 | 1 |
| Disposable Flow Sensor (Fluonic, Inc) | 97 | 1 |
| External Drug Delivery System (Eksigent Technologies, LLC) | 97 | 1 |
| Drop Controlling/Counting Valve | 97 | 1 |
| Needle-Free Injections | 98 | 1 |
| Needle-Free Injections - List of Pipeline Products | 98 | 1 |
| Needle-Free Injections - Profiles of Pipeline Products | 98 | 1 |
| E-Jet 500 Needle-Free Injector (EuroJet Medical Inc) | 98 | 1 |
| Intradermal Syringe (Bioject Medical Technologies Inc.) | 99 | 1 |
| MicroDose Needle-Free System | 99 | 1 |
| Zeneo ID Human Needle-free Injection Device (Crossject) | 99 | 1 |
| Peripherally Inserted Central Catheter | 99 | 1 |
| Peripherally Inserted Central Catheter - List of Pipeline Products | 99 | 1 |
| Peripherally Inserted Central Catheter - Profiles of Key Pipeline Products | 99 | 1 |
| COVERT POWERPICC (C.R. Bard, Inc.) | 99 | 1 |
| Transdermal Drug Delivery Devices | 100 | 1 |
| Transdermal Drug Delivery Devices - List of Pipeline Products | 100 | 2 |
| Transdermal Drug Delivery Devices - Profiles of Key Pipeline Products | 102 | 1 |
| DermAll Patch (Genetic Immunity, LLC) | 102 | 1 |
| DrugMAT (TheraJect, Inc.) | 102 | 1 |
| FC Patch (Bayer HealthCare AG) | 102 | 1 |
| Non-Invasive Needle-Free Skin Patch (Extend Biosciences) | 102 | 1 |
| VaxMAT (TheraJect, Inc) | 102 | 1 |
| Transmucosal Drug Delivery Devices | 103 | 1 |
| Transmucosal Drug Delivery Devices - List of Pipeline Products | 103 | 1 |
| Transmucosal Drug Delivery - Profiles of Key Pipeline Products | 104 | 1 |
| ARX-01 Sufentanil NanoTab PCA System (AcelRx Pharmaceuticals, Inc.) | 104 | 1 |
| Bactoprene (OVATECH,Inc.) | 104 | 1 |
| Ring HIV (OVATECH,Inc.) | 104 | 1 |
| Multi-Segmented Vaginal Ring (Combinent BioMedical Systems, Inc.) | 104 | 1 |
| Inhalable Drug Delivery Devices | 105 | 1 |
| Inhalable Drug Delivery Devices - List of Pipeline Products | 105 | 1 |
| Inhalable Drug Delivery - Profiles of Key Pipeline Products | 106 | 1 |
| AFREZZA - Medtone Inhaler (MannKind Corporation) | 106 | 1 |
| Inhaled Insulin Device (Dance Pharmaceuticals) | 106 | 1 |
| ProMaxx Microsphere Technology (Baxter International Inc.) | 106 | 1 |
| Respimat Soft Mist Inhaler (Boehringer Ingelheim GmbH) | 106 | 1 |
| Niche Technologies | 107 | 1 |
| Niche Technologies - List of Pipeline Products | 107 | 1 |
| Niche Technologies - Profiles of Key Pipeline Products | 108 | 1 |
| Nanonc Drug Delivery System (Nanonc Inc.) | 108 | 1 |
| Ultrasound Mediated Drug Delivery Device (Philips Healthcare) | 108 | 1 |
| DC Bead | 108 | 1 |
| Personalized Molecular Drug-delivery System | 108 | 1 |
| Global Drug Delivery Device Market - Consolidation Landscape | 109 | 7 |
| Deals by Count, 2007-2010 | 109 | 3 |
| Key Deals in 2007-2010 | 112 | 1 |
| Hisamitsu Pharmaceutical Completes Acquisition of Noven Pharmaceuticals | 112 | 1 |
| Overview | 112 | 1 |
| Deal Rationale | 112 | 1 |
| Deals Analysis | 112 | 1 |
| Company Profile | 112 | 1 |
| Kimberly-Clark Completes Acquisition of I-Flow | 113 | 1 |
| Overview | 113 | 1 |
| Deal Rationale | 113 | 1 |
| Deal Analysis | 113 | 1 |
| Company Profile | 114 | 1 |
| Surmodics Acquires Brookwood Pharmaceuticals | 114 | 1 |
| Overview | 114 | 1 |
| Deal Rationale | 114 | 1 |
| Deal Analysis | 114 | 1 |
| Company Profile | 115 | 1 |
| Appendix | 116 | 5 |
| Definitions | 116 | 2 |
| Drug Delivery Devices | 116 | 1 |
| Central Venous Catheters | 116 | 1 |
| Infusion Systems | 116 | 1 |
| Needle-Free Injections | 117 | 1 |
| Metered Dose Inhaler Devices | 117 | 1 |
| Acronyms | 117 | 1 |
| Research Methodology | 118 | 2 |
| Secondary Research | 118 | 1 |
| Primary Research | 118 | 1 |
| Models | 119 | 1 |
| Forecasts | 119 | 1 |
| Expert Panel | 119 | 1 |
| Contact Us | 119 | 1 |
| Disclaimer | 120 | 1 |
| Sources | 120 | 1 |